Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.

@article{GarcaGonzlez2006CardiogenicSA,
  title={Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.},
  author={Mart{\'i}n Jes{\'u}s Garc{\'i}a-Gonz{\'a}lez and Alberto Dominguez-Rodriguez and Julio J Ferrer-Hita and Pedro Abreu-Gonzalez and Miguel Bethencourt Mu{\~n}oz},
  journal={European journal of heart failure},
  year={2006},
  volume={8 7},
  pages={723-8}
}
BACKGROUND Levosimendan is a new calcium sensitizer with positive inotropic properties. Cardiac power output (CPO) has been shown to be instrumental in the diagnosis of cardiogenic shock (CS) and is an important determinant of outcomes. AIMS To evaluate the haemodynamic effects of levosimendan compared to dobutamine in acute myocardial infarction (AMI) patients revascularised by primary percutaneous coronary intervention (PCI), who developed CS. METHODS AND RESULTS Twenty two consecutive… CONTINUE READING